EDGAR Filing Documents for 0001179110-17-002279

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-17-002279

Filing Date

2017-02-13

Accepted

2017-02-13 17:17:06

Documents

Period of Report

2017-02-10

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	4011
	Complete submission text file	0001179110-17-002279.txt		5486

Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139

Business Address

Type: 4 | Act: 34 | File No.: 001-37813 | Film No.: 17600686

Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139

Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations